SPC
IMVT icon

Sigma Planning Corp’s Immunovant IMVT Stock Holding History

Sigma Planning Corp’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,965
Closed -$306K – 1017
2023
Q3 		$306K Sell
7,965
-3,935
-33% -$88.9K 0.01% 911
2023
Q2 		$226K Sell
11,900
-39,900
-77% -$744K 0.01% 1051
2023
Q1 		$803K Sell
51,800
-3,600
-6% -$62.5K 0.03% 598
2022
Q4 		$983K Buy
+55,400
New +$698K 0.04% 486

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Sigma Planning Corp's IMVT Position: Q4 2023 in Review

Sigma Planning Corp sold out of Immunovant (IMVT) in Q4 2023, closing a stake of 7,965 shares — an estimated $306K sold.

Sigma Planning Corp first reported a position in IMVT in Q4 2022 and held it in 4 quarters. The position peaked at $983K in Q4 2022. 228 funds tracked by Wall St. Rank hold IMVT as of Q4 2023.

  • Sigma Planning Corp reported no remaining Immunovant position as of Q4 2023 after selling out during the quarter.
  • Sigma Planning Corp sold 7,965 Immunovant shares in Q4 2023, an estimated $306K.
  • Sigma Planning Corp first reported a position in Immunovant in Q4 2022 and held it in 4 quarters.
  • Sigma Planning Corp's Immunovant position peaked at $983K in Q4 2022.
  • 228 funds tracked by Wall St. Rank held Immunovant as of Q4 2023.

Based on Sigma Planning Corp's 13F filing for Q4 2023, filed 1 Feb 2024.